C-B-D In Synergy w/ Myeloma

Herein, we also found that the C-B-D and T-H-C combination is able to reduce expression of the β5i subunit as well as to act in synergy with Carfilzomib to increase Myeloma cell death and inhibits cell migration

The bad news is that you have been diagnosed with an incurable blood cancer called multiple myeloma. The good news is that there is a long and growing list of both conventional (FDA approved) and evidence-based non-conventional therapies. C-B-D is about as non-conventional as they come.

But here is the interesting thing. C-B-D has been shown to be cytoxic to MM by itself and even more cytotoxic to MM when combined with T-H-C (the cannabinoid that gives the high) and C-B-D enhances two key MM chemotherapies, carfilzomib and bortezomib (aka kyprolis and velcade).

Oh yeah, one more thing. C-B-D is good for your bones. This is a big plus for MMers.

This next part of the blog is…less than evidence-based. Meaning I can’t cite studies when I say that the C-B-D oil used must be of a reasonably high percentage. I have read that C-B-D purchased over the internet (fall of ’18) is less than 5% cannabinoids. My understanding is that MMers need a C-B-D oil that is upwards of 25% cannabinoids.

The bottom line is that MMers must think outside the conventional oncology box. Yes, conventional MM therapies are often needed to control one’s MM. However if we are to stay ahead of the toxicity common with chemotherapy regimens and if we are to stay away from MDR (multi-drug resistence) and if we want to lengthen and deepen remissions, then we need to look beyond conventional MM oncology.

Please watch the video below to learn more about the evidence-based, integrative therapies to combat treatment side effects and enhance your chemotherapy.

Have you been diagnosed with multiple myeloma? What stage? What is your therapy plan? Please scroll down the page, post a question or comment and I will reply to you ASAP.

To Learn More about Sensitizing Myeloma- click now

Thank you,

David Emerson

Myeloma Survivor
Myeloma Cancer Coach
Director PeopleBeatingCancer

Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration

“Several studies showed a potential anti-tumor role for cannabinoids, by modulating cell signaling pathways involved in cancer cell proliferation, chemo-resistance and migration. Cannabidiol (CBD) was previously noted in multiple myeloma (MM), both alone and in synergy with the proteasome inhibitor bortezomib, to induce cell death.

In other type of human cancers, the combination of CBD with Δ⁹-tetrahydrocannabinol (THC) was found to act synergistically with other chemotherapeutic drugs suggesting their use in combination therapy.

In the current study, we evaluated the effects of T-H-C alone and in combination with C-B-D in MM cell lines. We found that CBD and THC, mainly in combination, were able to reduce cell viability by inducing autophagic-dependent necrosis. Moreover, we showed that the CBD-THC combination was able to reduce MM cells migration by down-regulating expression of the chemokine receptor CXCR4 and of the CD147 plasma membrane glycoprotein.

Furthermore, since the immuno-proteasome is considered a new target in MM and also since carfilzomib (CFZ) is a new promising immuno-proteasome inhibitor that creates irreversible adducts with the β5i subunit of immuno-proteasome, we evaluated the effect of CBD and THC in regulating the expression of the β5i subunit and their effect in combination with CFZ.

Herein, we also found that the CBD and THC combination is able to reduce expression of the β5i subunit as well as to act in synergy with CFZ to increase MM cell death and inhibits cell migration. In summary, these results proved that this combination exerts strong anti-myeloma activities…”

The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.

“Multiple myeloma (MM) is a plasma cell (PC) malignancy characterised by the accumulation of a monoclonal PC population in the bone marrow (BM). Cannabidiol (CBD) is a non-psychoactive cannabinoid with antitumoural activities, and the transient receptor potential vanilloid type-2 (TRPV2) channel has been reported as a potential CBD receptor.

Because bortezomib (BORT) is commonly used in MM treatment, we investigated the effects of CBD and BORT in CD138+TRPV2- MM cells and in MM cell lines transfected with TRPV2 (CD138+TRPV2+).

These results showed that CBD by itself or in synergy with BORT strongly inhibited growth, arrested cell cycle progression and induced MM cells death by regulating the ERK, AKT and NF-κB pathways with major effects in TRPV2+ cells. These data provide a rationale for using CBD to increase the activity of proteasome inhibitors in MM.

No bones about it: Cannabis may be used to treat fractures

“A new study published in the Journal of Bone and Mineral Research by Tel Aviv University and Hebrew University researchers explores another promising new medical application for marijuana. According to the research, the administration of the non-psychotropic component cannabinoid cannabidiol (CBD) significantly helps heal bone fractures. The study, conducted on rats with mid-femoral fractures, found that CBD — even when isolated from tetrahydrocannabinol (THC), the major psychoactive component of cannabis — markedly enhanced the healing process of the femora after just eight weeks…”

The Most BioAvailable Curcumin Formulas

“Based on a review of these studies, it is evident that better bioavailability of formulated curcumin (CU) products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism”

A search of the Pubmed database for the word curcumin yields 601 studies spaning health topics from multiple myeloma and colorectal cancer, to chemotherapies that synergizes with CU, to Alzheimer’s Disease, arthritis and more. Based on years of reading studies and personal accounts, I think it is safe to say that CU supplementation is safe and relatively inexpensive.

I have read about myeloma patients taking daily doses of CU from 400 milligrams to 8 grams (1000 milligrams = 1 gram). By almost any measure, CU is a safe, inexpensive wonder drug.

The only challenge is that CU is famously difficult to absorb in the body. In other words, a person has to mix curcumin with some sort of fat (coconut oil, chocolate, etc.) or take a brand of curcumin capsule that is already formulated to be more “bioavailable” in order to derive the full benefit of CU.

The study linked and exerpted below reviews different formulations of CU. The study itself lists the three most bioavailable formulation/brand of CU and I’ve added an excerpt from a further review from Consumerlab.com that lists four additional bioavailable brands of CU.

Curcumin

“CU is a bright yellow chemical produced by some plants. It is the principal curcuminoid of turmeric (Curcuma longa), a member of the ginger family, Zingiberaceae. It is sold as an herbal supplement, cosmetics ingredient, food flavoring, and food coloring.^[1]“

Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers.

“Curcumin is a widely studied natural compound which has shown tremendous in vitro therapeutic potential. Despite that, the clinical efficacy of the native CU is weak due to its low bioavailability and high metabolism in the gastrointestinal tract. During the last decade, researchers have come up with different formulations with a focus on improving the bioavailability of curcumin. As a result, a significant number of bioavailable curcumin-based formulations were introduced with the varying range of enhanced bioavailability.

The purpose of this review is to collate the published clinical studies of CU products with improved bioavailability over conventional (unformulated) CU. Based on the literature search, 11 curcumin formulations with available human bioavailability and pharmacokinetics data were included in this review. Further, the data on clinical study design, analytical method, pharmacokinetic parameters and other relevant details of each formulation were extracted.

Based on a review of these studies, it is evident that better bioavailability of formulated curcumin products is mostly attributed to improved solubility, stability, and possibly low first-pass metabolism. The review hopes to provide a quick reference guide for anyone looking information on these bioavailable curcumin formulations.

Based on the published reports,

NovaSol® (185 x),
CurcuWin® (136 x ) and
LongVida® (100 x )

exhibited over 100-fold higher bioavailability relative to reference unformulated CU. Suggested mechanisms accounting for improved bioavailability of the formulations and details on the bioanalysis methods are also discussed.”

According to Consumerlab.com:

“Novasol has the highest bioavailability (185 x compared to unforumulated CU), followed by Curcuwin (136 x), Longvida (100 x), Meriva (48 x), BCM-95 (27 x), Curcumin C3 Complex + Bioperene (20 x), and then Theracumin (16 x).”

APPIP ERROR: amazonproducts[
AccessDeniedAwsUsers|The Access Key Id AKIAJAJ37JVNL7OUU4CA is not enabled for accessing this version of Product Advertising API. Please migrate your credentials as referred here https://webservices.amazon.com/paapi5/documentation/migrating-your-product-advertising-api-account-from-your-aws-account.html.
]

Velcade Quercetin Synergism Myeloma - PeopleBeatingCancer says a few months ago

[…] C-B-D In Synergy w/ Myeloma […]

Multiple Myeloma Treatment- CBD w/ Velcade, Darzalex, Kyprolis? - PeopleBeatingCancer says 3 years ago

[…] C-B-D In Synergy w/ Myeloma Chemotherapy […]

Multiple Myeloma- Intravenous Vitamin C Therapy - PeopleBeatingCancer says 4 years ago

Cannabidiol (CBD) as Multiple Myeloma therapy- PeopleBeatingCancer says 4 years ago

Multiple Myeloma Cause- HPV? Maitake, Shiitake, AHCC - PeopleBeatingCancer says 4 years ago

Multiple Myeloma Remission- CBD Synergizes w/ Carfilzomib - PeopleBeatingCancer says 4 years ago

Dichloroacetate (DCA) as Multiple Myeloma Therapy - PeopleBeatingCancer says 4 years ago

[…] C-B-D In Synergy w/ Myeloma Chemotherapy– […]

Newly Diagnosed Multiple Myeloma, Burzynski, Antineoplaston Therapy says 5 years ago

Multiple Myeloma + Intravenous Vitamin C - PeopleBeatingCancer says 5 years ago

Multiple Myeloma and Human Papilloma Virus (HPV) - PeopleBeatingCancer says 5 years ago

Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

C-B-D In Synergy w/ Myeloma

Recommended Reading:

Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration

The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.

No bones about it: Cannabis may be used to treat fractures

The Most BioAvailable Curcumin Formulas

Recommended Reading:

Curcumin

Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers.

Leave a Comment:

10 comments

Popular posts

Multiple Myeloma Diet

Multiple Myeloma Survivor- A Different kind of Second Opinion-

C-B-D Enhances Velcade (BORT)

Are Endometrial Polyps Overtreated?